XML 53 R24.htm IDEA: XBRL DOCUMENT
v3.21.1

Share Capital, Warrants and Options (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2021
SHARE CAPITAL, WARRANTS AND OPTIONS |
Schedule of Number and Weighted Average Exercise Prices of Warrants | A summary of common share purchase warrants activity during the three months period ended March 31, 2021 is as follows:
|  | March 31, 2021 |  |  | December 31, 2020 |
|  | Number Outstanding |  |  | Weighted Average Exercise Price ($) |  |  | Number Outstanding |  |  | Weighted Average Exercise Price ($) |
Outstanding, beginning of the period |  |  | 25,715,742 |  |  |  | 0.11 |  |  |  | 15,651,397 |  |  |  | 0.96 |
Issued |  |  | - |  |  |  | - |  |  |  | 21,731,011 |  |  |  | 0.09 |
Exercised |  |  | (6,278,219 | ) |  |  | 0.11 |  |  |  | - |  |  |  | - |
Cancelled / expired |  |  | - |  |  |  | - |  |  |  | (11,666,666 | ) |  |  | 1.20 |
Outstanding, end of the period |  |  | 19,437,523 |  |  |  | 0.12 |  |  |  | 25,715,742 |  |  |  | 0.11 |
Schedule of Number and Weighted Average Remaining Contractual Life of Outstanding Warrants | At March 31, 2021, the Company had outstanding common share purchase warrants exercisable to acquire common shares of the Company as follows:
Warrants Outstanding |  |  | Expiry Date |  | Exercise Price ($) |  |  | Weighted Average remaining contractual life (years) |
| 3,359,133 |  |  | December 18, 2021 |  |  | 0.25 |  |  |  | 0.12 |
| 12,535,581 | 1 |  | August 13, 2022 |  |  | 0.09 |  |  |  | 0.88 |
| 3,542,809 | 1 |  | August 31, 2022 |  |  | 0.09 |  |  |  | 0.26 |
| 19,437,523 |  |  |  |  |  |  |  |  |  | 1.26 |
1 The warrants are subject to an acceleration clause such that if the volume-weighted average trading price of the Company’s common shares on the TSX-V exceeds $0.12 per common share for a period of 10 consecutive trading days at any date before the expiration date of such warrants, the Company may, at its option, accelerate the warrant expiry date to within 30 days. To March 31, 2021, the Company’s common shares have met the criterion for acceleration. The Company, however, has not accelerated the warrant expiry date.
Schedule of Number and Weighted Average Exercise Prices of Share Options | A summary of option activity under the Plan during the three months period ended March 31, 2021, is as follows:
|  | March 31, 2021 |  |  | December 31, 2020 |
|  | Number Outstanding |  |  | Weighted Average Exercise Price ($) |  |  | Number Outstanding |  |  | Weighted Average Exercise Price ($) |
Outstanding, beginning of the period |  |  | 7,978,725 |  |  |  | 0.17 |  |  |  | 2,130,550 |  |  |  | 1.51 |
Issued |  |  | 3,185,000 |  |  |  | 0.32 |  |  |  | 7,850,000 |  |  |  | 0.15 |
Cancelled / expired |  |  | (603,100 | ) |  |  | 0.33 |  |  |  | (2,001,825 | ) |  |  | 1.51 |
Outstanding, end of the period |  |  | 10,560,625 |  |  |  | 0.21 |  |  |  | 7,978,725 |  |  |  | 0.17 |
Schedule of Inputs to Option Pricing Model | The fair value of stock options granted and vested during the years ended March 31, 2021 was calculated using the following assumptions:
|  | March 31, 2021 |  |  | March 31, 2020 |
Expected dividend yield |  |  | 0 | % |  |  | 0 | %
Expected share price volatility |  |  | 127.83 | % |  |  | 121.55 | %
Risk free interest rate |  |  | 0.93 | % |  |  | 1.21 | %
Expected life of options |  |  | 5 years |  |  |  | 5 years |
Schedule of Number and Weighted Average Remaining Contractual Life of Outstanding Share Options | Details of options outstanding as at March 31, 2021 are as follows:
Options Outstanding |  |  | Options Exercisable |  |  | Expiry Date |  | Exercise Price ($) |  |  | Weighted average remaining contractual life (years) |
| 40,625 |  |  |  | 40,625 |  |  | February 21, 2022 |  |  | 1.20 |  |  |  | 0.00 |
| 35,000 |  |  |  | 35,000 |  |  | February 28, 2023 |  |  | 1.20 |  |  |  | 0.01 |
| 6,100,000 |  |  |  | 6,100,000 |  |  | February 24, 2025 |  |  | 0.16 |  |  |  | 2.27 |
| 1,200,000 |  |  |  | 1,200,000 |  |  | August 19, 2025 |  |  | 0.09 |  |  |  | 0.50 |
| 3,185,000 |  |  |  | 3,185,000 |  |  | February 25, 2026 |  |  | 0.32 |  |  |  | 1.49 |
| 10,560,625 |  |  |  | 10,560,625 |  |  |  |  |  |  |  |  |  | 4.27 |

X
- Definition Disclosure of Detailed number and weighted average remaining contractual life of outstanding warrants, explanatory. + References No definition available. + Details
Name: | WSCRF_DisclosureOfDetailedInformationAboutNumberAndWeightedAverageRemainingContractualLifeOfOutstandingWarrantsExplanatory
Namespace Prefix: | WSCRF_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | WSCRF_DisclosureOfShareCapitalWarrantsAndOptionsAbstract
Namespace Prefix: | WSCRF_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 47 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_47_a&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 45 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 45 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 45 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_d&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration